Navigation Links
International Rett Syndrome Foundation awards $2M for cutting-edge Rett syndrome research
Date:10/1/2009

improve quality of life and could provide the path to an eventual cure for Rett syndrome." Dr. Horton added: "These new studies will generate fresh insights that will enable us to better understand the mechanisms underlying Rett Syndrome. While there are no quick fixes, we will continue to be aggressive in our search for new treatments for the eventual pharmacological reversal of Rett Syndrome."

Regular Research Grants:

Nurit Ballas PhD, Stony Brook University
Analyzing the contribution of MeCP2-defficient oligodendrocyte-lineage cells to Rett syndrome neuropathology

Previous findings suggest that non-neuronal cell populations of the brain may be involved in causing the full spectrum of Rett syndrome symptoms, given that knocking out MeCP2 in neurons results in only a partial model of Rett syndrome. To date, studies have focused on neurons as the primary cause of Rett syndrome due to their high levels of MeCP2 and the difficulty to detect MeCP2 in glial cells in the brain. New detection techniques have been used in preliminary studies that suggest MeCP2 is present in certain glial cell types and that they may contribute to neuronal dysfunction in Rett syndrome by secreting factors that are potentially harmful to neurons. This proposal seeks to assess the role of MeCP2 loss in glial cells called oligodendrocytes and study how it contributes to the neuropathology of Rett syndrome. Developing the appropriate cellular models will help prove or disprove the real contribution of glial cells in Rett syndrome pathogenesis. In addition the study aims to further investigate possible secondary factors that could be manipulated to positively affect the course of Rett syndrome.

James Eubanks PhD, Toronto Western Research Institute
Assessing Phenotypic Improvement of MeCP2-Deficient Mice By Preservation or Reactivation of Functional MeCP2 in Catecholaminergic Cells

Dr. Eubanks proposes to deter
'/>"/>

Contact: Dr. Antony Horton
212-459-2608
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. International conference on endothelin
2. International event brings worlds top cancer doctors to Queens
3. Forest Service to host 2nd International Conference on Forests and Water in a Changing Environment
4. EMBO pioneers pension plan for internationally mobile postdoctoral researchers
5. International conference on CO2 sequestration processes
6. International research team seeks to unravel flatworm regeneration
7. Fujitsu PalmSecure Certified Under International Common Criteria Evaluation Assurance Level 2
8. Journal of Vascular and Interventional Radiology increases impact, international reach
9. International team of students and scientists on month-long field course in Siberian Arctic
10. ESHRE launches international study of polar body screening
11. International collaboration by scientists culminates in novel ion channels database
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)...   Atmel® Corporation (NASDAQ: ATML ... technology solutions, today launched the industry,s first family of ... V cc range from 1.7V to 5.5V. The ... 2 C bus communication speeds, and are available with ... ideal for consumer, industrial, computer, and medical applications. ...
(Date:11/18/2014)... 2014 The Parenteral Drug Association (PDA) today confirmed ... speak and at least seven more will participate in the ... Shoreham Hotel in Washington D.C. , Dec. ... significant support from the regulatory agencies in the ... in our effort to help advance the use of metrics ...
(Date:11/12/2014)... PALM BEACH GARDENS, Fla. , Nov. 12, 2014 ... management solutions, announced today that its U.are.U ® ... upscale retail bakery chain in Central Mexico ... solution in June 2014 to eliminate payroll issues caused ... Prior to installing the U.are.U fingerprint readers, Montparnasse ...
Breaking Biology News(10 mins):Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... Biomedical and Chemical Engineering at L.C. Smith College of ... commonly used nanoparticles, particles up to one million times ... damage cell membranes. In a recent article ... Langmuir entitled "Effects of nanoparticle charge and ...
... A study led by Robert G. Hawley, Ph.D., ... and regenerative biology at the George Washington University ... may help predict which patients with multiple myeloma ... titled "Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma ...
... MA) -- Microbiologists who study wild marine microbes, as opposed ... clear picture of the daily activities of their subjects. But ... Aquarium Research Institute recently figured out how to make the ... many coexisting species in their native habitat over time. ...
Cached Biology News:Modifications of a nanoparticle can change chemical interactions with cell membranes 2New research may aid treatment of multiple myeloma patients 2New research may aid treatment of multiple myeloma patients 3Microbiologists eavesdrop on the hidden lives of microbes 2Microbiologists eavesdrop on the hidden lives of microbes 3
(Date:11/26/2014)... -- Roka Bioscience, Inc. (NASDAQ: ROKA ), a molecular ... detection of foodborne pathogens, today announced that Paul G. ... Annual Healthcare Conference on December 2, 2014 at 4:30pm ... Palace in New York, NY . ... its operations, strategies and prospects may be discussed. To listen ...
(Date:11/24/2014)... AMSTERDAM , November 24, 2014 ... free online on ScienceDirect   Elsevier , ... and services, is pleased to announce the launch of the ... : Current Opinion in Food Science ... will provide specialists with a new platform to keep ...
(Date:11/24/2014)... 24, 2014 The new video, ... METTLER TOLEDO demonstrates how to reduce the number ... and sample panel design can be complicated, requiring ... protect against corrosion and deposition. Dedicated single and ... amount of panel space. Additionally, installing and maintaining ...
(Date:11/22/2014)... 2014 During his lifetime Richard L. ... to surround himself with great people and take risks ... friends often marveled at his extraordinarily courageous attitude when ... and -- even with his death impending—that’s how he ... that would ultimately take his life. , Carrying on ...
Breaking Biology Technology:Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3New Video Shows How to Simplify Cycle Chemistry Sample Panels to Save Time and Costs 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 2Sherry Sharp, Wife of CarMax Founder, Richard Sharp, Accepts Seat on Board of Cure Alzheimer’s Fund 3
... Third Quarter Net Revenues Up 98% and Adjusted ... 12 /Xinhua-PRNewswire/ -- WuXi PharmaTech,(Cayman) Inc. (NYSE: ... research and development outsourcing company with operations,in China ... financial,results for the third quarter ended September 30, ...
... Beckman,Coulter, Inc. (NYSE: BEC ), a ... simplify, automate, and innovate complex biomedical,testing, announced ... vice,president and chief financial officer, will present ... Conference on Tuesday, November 18, 2008 at,4:40 ...
... LINCOLN, Neb., Nov. 12 Protease substrates provide ... of inhibitors,and screen compound collections for discovery of ... NIR-FRET Protease Substrates:,IRDye 800CW/QC-1 HIV-1, IRDye 800CW/QC-1 BACE, ... low intrinsic fluorescence due to self-quenching,of the conjugated ...
Cached Biology Technology:WuXi PharmaTech Announces Third Quarter 2008 Results 2WuXi PharmaTech Announces Third Quarter 2008 Results 3WuXi PharmaTech Announces Third Quarter 2008 Results 4WuXi PharmaTech Announces Third Quarter 2008 Results 5WuXi PharmaTech Announces Third Quarter 2008 Results 6WuXi PharmaTech Announces Third Quarter 2008 Results 7WuXi PharmaTech Announces Third Quarter 2008 Results 8WuXi PharmaTech Announces Third Quarter 2008 Results 9WuXi PharmaTech Announces Third Quarter 2008 Results 10WuXi PharmaTech Announces Third Quarter 2008 Results 11WuXi PharmaTech Announces Third Quarter 2008 Results 12WuXi PharmaTech Announces Third Quarter 2008 Results 13LI-COR Introduces Three IRDye(R) Near-Infrared Fluorescence Resonance Energy Transfer (NIR-FRET) Protease Substrates 2